99D-17527-98269
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 194 / PA
- Registered
- 2021-11-14
- Relationship
- Child or adolescent in my care
- Guardian
- C6Q-90411-96327
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-13
Dose 1 — Pfizer-BioNTech
-
2021-11-14
Registered in v-safe
- 2021-11-14
- 2021-11-16
- 2021-11-20
- 2021-11-27
-
2021-12-04
Dose 2 — Pfizer-BioNTech
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-18
- 2021-12-25
-
2022-01-01
Survey response — day 28, dose 2, dependentMedDRA: Allergic respiratory symptom, Eye pruritus, Nasal congestion — Feeling: GoodFree text: Increased allergy-like symptoms. Nasal Congestion. Itchy eyesMedDRA releases: 2024-11 · check-in free text available
- 2022-01-08
- 2022-01-15
- 2022-03-05
- 2022-06-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-13 | Pfizer-BioNTech | No |
| 2 | 2021-12-04 | Pfizer-BioNTech | No |
Free text
Release 10 — day 28, dose 2, dependent
Symptoms: Increased allergy-like symptoms. Nasal Congestion. Itchy eyes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Allergic respiratory symptom | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release